Incubators

The contract involves procuring multiple incubators to replace malfunctioning units essential for microbiological analysis, particularly for pathogen testing. These incubators are critical for ensuring reliable and accurate microbiological evaluations. The Food and Drug Administration (FDA) is the procuring agency, with the solicitation posted in March 2026. Although specific details such as the solicitation number and office location are not provided, the acquisition is tied to the NAICS code 334516, which relates to laboratory equipment manufacturing. Key contacts include a program point of contact reachable via an FDA email address, while the contracting officer's details have yet to be determined. This procurement is a forecast opportunity aimed at supporting the FDA’s ongoing operational needs for reliable incubation equipment.